Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment. This work of course has it´s challenges.
One challenge in cancer treatments is to give the right medicine to the right patient at the right time. This is called precision medicine and means that cancer treatments can to a greater extent be tailored to the individual patient. Another big challenge is to shorten the development time for new cancer medicines. The corona pandemic has shown us that it is possible to quickly develop new treatments, initiate clinical studies and gather data. The analysis of health data will be essential for the development and approval of new treatments. A third challenge is how we involve the cancer patient in their own treatment. During this seminar Ketil Widerberg (CEO) and Øyvind Kongstun Arnesen (Chairman of the Board) will give you insights into how Oslo Cancer Cluster addresses these challenges.
Oslo Cancer Cluster is a national non-profit member organization with 90+ members. Our member base comprises university hospitals, research centers, patient organizations, start-ups and biotech companies, global pharma and technology companies, investors, financial institutions as well as service providers – all working in the cancer field. Jointly, they cover the entire oncology value chain – from exploratory research to delivering novel therapeutics and diagnostics to patients worldwide. https://oslocancercluster.no/